{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:00:26Z","timestamp":1790719226683,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cld.2021.02.001","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:44:21Z","timestamp":1615423461000},"page":"461-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Invasive Procedures in Patients with Cirrhosis"],"prefix":"10.1016","volume":"25","author":[{"given":"Annabel","family":"Blasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2021.02.001_bib1","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: Evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cld.2021.02.001_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcrc.2017.07.053","article-title":"Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure","volume":"43","author":"Fisher","year":"2018","journal-title":"J\u00a0Crit Care"},{"issue":"35","key":"10.1016\/j.cld.2021.02.001_bib3","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.3748\/wjg.v21.i35.10062","article-title":"Coagulopathy in liver disease: lack of an assessment tool","volume":"21","author":"Blasi","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2021.02.001_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2021.02.001_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0037-1615058","article-title":"Increased thromboxane metabolites excretion in liver cirrhosis","volume":"79","author":"Dav\u00ec","year":"1998","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.cld.2021.02.001_bib6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/lt.20195","article-title":"Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation","volume":"10","author":"Trotter","year":"2004","journal-title":"Liver Transplant"},{"issue":"3","key":"10.1016\/j.cld.2021.02.001_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.thromres.2013.05.032","article-title":"The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index","volume":"132","author":"Magnusson","year":"2013","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.cld.2021.02.001_bib8","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2021.02.001_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.28628","article-title":"Coagulation parameters and major bleeding in critically ill patients with cirrhosis","volume":"64","author":"Drolz","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2021.02.001_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/bja\/aep098","article-title":"Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in\u00a0vitro model","volume":"102","author":"Bolliger","year":"2009","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.cld.2021.02.001_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1172\/JCI108773","article-title":"Dysfibrinogenemia associated with liver disease","volume":"60","author":"Palascak","year":"1977","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.cld.2021.02.001_bib12","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/j.thromres.2010.09.004","article-title":"Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia","volume":"126","author":"Miesbach","year":"2010","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.cld.2021.02.001_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0037-1599154","article-title":"Point-of-care testing in liver disease and liver surgery","volume":"43","author":"Abeysundara","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"10.1016\/j.cld.2021.02.001_bib14","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/jth.12706","article-title":"Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity","volume":"12","author":"Kleinegris","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cld.2021.02.001_bib15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hep.28148","article-title":"Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial","volume":"63","author":"De Pietri","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2021.02.001_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.5500\/wjt.v6.i3.583","article-title":"Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation","volume":"6","author":"De Pietri","year":"2016","journal-title":"World J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2021.02.001_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bpa.2020.03.002","article-title":"Coagulation, hemostasis, and transfusion during liver transplantation","volume":"34","author":"Thai","year":"2020","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"4","key":"10.1016\/j.cld.2021.02.001_bib18","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1053\/j.jvca.2017.10.011","article-title":"Development of a predictive model for blood transfusions and bleeding during liver transplantation: an observational cohort study","volume":"32","author":"Massicotte","year":"2018","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"3","key":"10.1016\/j.cld.2021.02.001_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tmrv.2014.03.002","article-title":"Hemostasis in liver disease: Implications of new concepts for perioperative management","volume":"28","author":"Weeder","year":"2014","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.cld.2021.02.001_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.1985.tb02974.x","article-title":"Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions","volume":"59","author":"Fernandez","year":"1985","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.cld.2021.02.001_bib21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.14522","article-title":"Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity","volume":"47","author":"Mandorfer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2021.02.001_bib22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2016.06.002","article-title":"von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia","volume":"65","author":"Kalambokis","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.02.001_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gft209","article-title":"Haemostasis in chronic kidney disease","volume":"29","author":"Lutz","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.cld.2021.02.001_bib24","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","volume":"30","author":"Patel","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"9","key":"10.1016\/j.cld.2021.02.001_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/10245332.2018.1452456","article-title":"Evaluation of hypercoagulability with rotational thromboelastometry in children with iron deficiency anemia","volume":"23","author":"\u00d6zdemir","year":"2018","journal-title":"Hematology"},{"issue":"5","key":"10.1016\/j.cld.2021.02.001_bib26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2001.03781.x","article-title":"Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit","volume":"96","author":"Hu","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.02.001_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/gut.15.2.99","article-title":"The portal pressure-blood volume relationship in cirrhosis","volume":"15","author":"Zimmon","year":"1974","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2021.02.001_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2021.02.001_bib29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cgh.2010.06.018","article-title":"Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease","volume":"8","author":"Giannini","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.02.001_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical practice update: coagulation in cirrhosis","volume":"157","author":"O'Leary","year":"2019","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2021.02.001_bib31","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1055\/s-0038-1666861","article-title":"Concepts and controversies in haemostasis and thrombosis associated with liver disease: proceedings of the 7th international coagulation in liver disease conference","volume":"118","author":"Intagliata","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cld.2021.02.001_bib32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cgh.2009.04.019","article-title":"A\u00a0prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation","volume":"7","author":"Vieira da Rocha","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2021.02.001_bib33","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","author":"Northup","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.02.001_bib34","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.30561","article-title":"Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2)","volume":"70","author":"Peck-Radosavljevic","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.02.001_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","article-title":"Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia","volume":"155","author":"Terrault","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.02.001_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jhep.2019.09.008","article-title":"Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation","volume":"72","author":"Rassi","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.02.001_bib37","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.0041-1132.2004.04347.x","article-title":"Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel","volume":"44","author":"Kleinman","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.cld.2021.02.001_bib38","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.22216","article-title":"Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial","volume":"47","author":"Bosch","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2021.02.001_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF03016538","article-title":"Reduction of blood product transfusions during liver transplantation","volume":"52","author":"Massicotte","year":"2005","journal-title":"Can J Anaesth"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:57:36Z","timestamp":1761069456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326121000131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1089326121000131"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2021.02.001","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive Procedures in Patients with Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2021.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}